Profile
| Metric | Value |
|---|---|
| Full Name | Context Therapeutics Inc. |
| Ticker | NASDAQ: CNTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | contexttherapeutics.com |
| Employees | 12 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $1.53 | |
| Price, 1D Change | -4.97% | |
| $141M | ||
| - | ||
| - | ||
| 1.00 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.46 | ||
| EPS, 1Y Change | +69.52% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.46 | ||
| EPS Estimate | N/A | -$0.35 |
| EPS Est. Change | N/A | +23.50% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $1.53 | |
| Price Target | - | $5.00 |
| Price Tgt. Change | - | +226.80% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.58 | -$0.46 | +21.12% | |
| -$0.35 | N/A | +23.50% | |
| -$0.41 | N/A | +9.55% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $1.53 | |
| $0.92 | ||
| SMA 200 vs Price | -39.99% | |
| $1.19 | ||
| SMA 50 vs Price | -22.33% | |
| 1.00 | ||
| $0.15 | ||
| 71.21 | ||
| 81.88% | ||
| 91.19% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.46 | ||
| -$52.70K | ||
| - | ||
| -$29.92M | ||
| - | ||
| -$26.73M | ||
| - | ||
| -$29.91M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 35.55 | ||
| 35.62 | ||
| - | ||
| - | ||
| 28.29 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.92 | ||
| -2.11 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $95.27M | ||
| $94.43M | ||
| $98.13M | ||
| $97.90M | ||
| $2.86M | ||
| $2.75M | ||
| $219.40K | ||
| $107.30K | ||
| $1.45M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $29.92M | ||
| $29.92M | ||
| $52.70K | ||
| $7.22M | ||
| $52.70K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$14.56M | ||
| -$14.76M | ||
| $109.29M | ||
| $14.76M | ||
| -$29.31M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Jones Trading | ||
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| Cantor Fitzgerald | ||
| Guggenheim | ||
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| Piper Sandler | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with CNTX
Data Sources & References
- CNTX Official Website www.contexttherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1842952/000184295225000028/0001842952-25-000028-index.htm
- CNTX Profile on Yahoo Finance finance.yahoo.com/quote/CNTX
- CNTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cntx
FAQ
What is the ticker symbol for Context Therapeutics Inc.?
The ticker symbol for Context Therapeutics Inc. is NASDAQ:CNTX
Does Context Therapeutics Inc. pay dividends?
No, Context Therapeutics Inc. does not pay dividends
What sector is Context Therapeutics Inc. in?
Context Therapeutics Inc. is in the Healthcare sector
What industry is Context Therapeutics Inc. in?
Context Therapeutics Inc. is in the Biotechnology industry
What country is Context Therapeutics Inc. based in?
Context Therapeutics Inc. is headquartered in United States
When did Context Therapeutics Inc. go public?
Context Therapeutics Inc. initial public offering (IPO) was on October 20, 2021
Is Context Therapeutics Inc. in the S&P 500?
No, Context Therapeutics Inc. is not included in the S&P 500 index
Is Context Therapeutics Inc. in the NASDAQ 100?
No, Context Therapeutics Inc. is not included in the NASDAQ 100 index
Is Context Therapeutics Inc. in the Dow Jones?
No, Context Therapeutics Inc. is not included in the Dow Jones index
When was Context Therapeutics Inc. last earnings report?
Context Therapeutics Inc.'s most recent earnings report was on November 10, 2022
When does Context Therapeutics Inc. report earnings?
The date for Context Therapeutics Inc.'s next earnings report has not been announced yet